The optimal concentrations for a niacinamide zinc spot gel depend on your target consumer, intended claims, regulatory markets, and the stability constraints your contract manufacturer can reliably meet at scale.
Niacinamide is clinically well-characterised. Concentrations of 2–5% are effective for pore appearance and uneven skin tone with a very low likelihood of skin sensitivity. Concentrations of 5–10% are associated with stronger sebum-regulation, anti-inflammatory, and post-blemish mark-fading effects. Most successful commercial spot gels in the 2020s launch at 10% niacinamide because the published clinical literature at that level is extensive and consumers have become ingredient-literate enough to recognise the benchmark. Above 10%, diminishing returns are documented and the risk of niacin-flush-like transient erythema in sensitive users increases — most cosmetic chemists do not recommend exceeding 10% without specific clinical justification.
For the zinc component, the most common choices are zinc gluconate, zinc PCA, and zinc sulfate. Zinc PCA (pyrrolidone carboxylic acid zinc salt) is the premium-positioning option: it combines zinc's sebostatic activity with PCA's humectant properties, producing a less drying skin feel than inorganic zinc salts. Effective use levels are typically 0.5–2% for zinc PCA and zinc gluconate. Zinc sulfate is cheaper but can feel astringent at effective concentrations. Zinc oxide, common in mineral sunscreens and barrier creams, is not the preferred zinc form in a lightweight gel due to its opacity and insolubility.
From a stability standpoint, niacinamide at high concentrations in aqueous gels must be formulated at pH 5.5–7.0. Below pH 4.5, niacinamide hydrolysis to nicotinic acid accelerates, which can cause flushing. Above pH 7.5, off-odour formation and yellowing risk increase. Your cosmetic chemist should provide you with pH data at T=0, 4 weeks, and 12 weeks under accelerated conditions.
Regulatory note: in no EU or US guidance document is niacinamide listed as a restricted or prohibited cosmetic ingredient at these concentrations, meaning there are no Annex III concentration caps to comply with for niacinamide specifically. Zinc compounds are another matter — zinc oxide in spray-format products is subject to EU restrictions. For a leave-on gel, zinc gluconate and zinc PCA have a well-established safety history and no current EU restriction, but this regulatory landscape is reviewed periodically by the Scientific Committee on Consumer Safety (SCCS), so confirmatory checks at time of launch are advisable.
If you intend to make acne-drug claims in the US, niacinamide is not currently included in the FDA OTC acne monograph — you cannot legally claim it treats acne as a drug active. Zinc acetate at 0.25% is an approved monograph active for anti-acne, but using it triggers full OTC drug compliance. Most brands correctly keep the formula in the cosmetic category and make permissible structure-function claims ("visibly reduces the look of blemishes").
Ingredients in this answer: Niacinamide · Zinc Oxide · Zinc PCA
Read the full guide on Private Label Niacinamide Zinc Spot Gel Manufacturer Low MOQ →